Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title:Meet Our Editorial Board Member:
Volume: 14 Issue: 1
Author(s): Francesco Epifano
Affiliation:
Export Options
About this article
Cite this article as:
Epifano Francesco, Meet Our Editorial Board Member:, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2015; 14 (1) . https://dx.doi.org/10.2174/187152301401150522123412
DOI https://dx.doi.org/10.2174/187152301401150522123412 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
27
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
<i>In Silico</i> Analysis, Synthesis, and Biological Evaluation of Triazole Derivatives as H1 Receptor Antagonist
Current Drug Discovery Technologies Analysis of Current Antifungal Agents and Their Targets within the Pneumocystis carinii Genome
Current Drug Targets Treating Chronic Hepatitis B: Today and Tomorrow
Current Medicinal Chemistry Recent Patents on Immunoregulatory DNA Vaccines for Autoimmune Diseases and Allograft Rejection
Recent Patents on DNA & Gene Sequences Current Updates on Role of Lipids in Hematopoiesis
Infectious Disorders - Drug Targets Endothelins and the Role of Endothelin Antagonists in the Management of Posttraumatic Vasospasm
Current Pharmaceutical Design A Comprehensive Literature Review of COPD-Related Fatigue
Current Respiratory Medicine Reviews Prostaglandin E2 Receptors as Potential Bone Anabolic Targets – Selective EP4 Receptor Agonists
Current Molecular Pharmacology Monitoring Therapy with Gene Expression Profiling Reveals Physiological Differences in Drug Action
Current Pharmaceutical Design Antagonism of Endothelin (ETA and ETB) Receptors During Renovascular Hypertension-Induced Vascular Dementia Improves Cognition
Current Neurovascular Research The Role of Combined Assessment of Defense Against Oxidative Stress and Inflammation in the Evaluation of Peripheral Arterial Disease
Current Molecular Medicine Exploring N<sup>1</sup>-p-Fluorobenzyl-Cymserine as an Inhibitor of 5-Lipoxygenase as a Candidate for Type 2 Diabetes and Neurodegenerative Disorder Treatment
CNS & Neurological Disorders - Drug Targets Role of Vascular Endothelial Growth Factor in Kidney Disease
Current Vascular Pharmacology Synthesis, Antitumor Activity, and Structure-activity Relationship of Some Benzo[a]pyrano[2,3-c]phenazine Derivatives
Combinatorial Chemistry & High Throughput Screening Developing Novel Therapeutic Approaches to Frailty
Current Pharmaceutical Design HLA-B27 is a Risk Factor for Rheumatoid Arthritis: Suggestion for an Evidence-based Update
Current Pharmacogenomics and Personalized Medicine Inflammation as a Therapeutic Target for Various Deadly Disorders: A Review
Current Drug Targets Patented Aptamers for C-Reactive Protein Detection: A Review About their Use in Clinical Diagnostics
Recent Patents on DNA & Gene Sequences Bioinformatics and Drug Discovery
Current Topics in Medicinal Chemistry New Perspectives in the Treatment of Cushings Syndrome
Current Drug Targets - Immune, Endocrine & Metabolic Disorders